Kennedy Capital Management’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-20,032
Closed -$1.6M 716
2018
Q4
$1.6M Sell
20,032
-4,971
-20% -$397K 0.04% 560
2018
Q3
$11.7M Buy
25,003
+6,774
+37% +$3.16M 0.22% 127
2018
Q2
$7.25M Buy
18,229
+15,221
+506% +$6.05M 0.14% 269
2018
Q1
$920K Sell
3,008
-275
-8% -$84.1K 0.02% 670
2017
Q4
$966K Buy
+3,283
New +$966K 0.02% 673